Table 2.

AME of eCIP introduction on penicillin use; CGI data on erysipelas care episodes in Turku OPAT, January 2018–January 2022

AME95% CIa
Study period after eCIP introduction0.3600.2550.465
Male patient−0.058−0.1450.029
Patient age at care episode0.002−0.0010.005
Patient comorbidities
 Hypertension−0.120−0.228−0.011
 Diabetes0.007−0.0980.112
 Venous insufficiency0.066−0.0720.205
 Arteriosclerosis obliteransb−0.069−0.2350.096
CRPc−0.001−0.0010.000
AME95% CIa
Study period after eCIP introduction0.3600.2550.465
Male patient−0.058−0.1450.029
Patient age at care episode0.002−0.0010.005
Patient comorbidities
 Hypertension−0.120−0.228−0.011
 Diabetes0.007−0.0980.112
 Venous insufficiency0.066−0.0720.205
 Arteriosclerosis obliteransb−0.069−0.2350.096
CRPc−0.001−0.0010.000

Table excluded 21 care episodes with missing information on CRP. Results from logistic models adjusted for within-patient clustering.

a

CI: confidence interval.

b

Peripheral artery disease.

c

CRP: C-reactive protein.

Table 2.

AME of eCIP introduction on penicillin use; CGI data on erysipelas care episodes in Turku OPAT, January 2018–January 2022

AME95% CIa
Study period after eCIP introduction0.3600.2550.465
Male patient−0.058−0.1450.029
Patient age at care episode0.002−0.0010.005
Patient comorbidities
 Hypertension−0.120−0.228−0.011
 Diabetes0.007−0.0980.112
 Venous insufficiency0.066−0.0720.205
 Arteriosclerosis obliteransb−0.069−0.2350.096
CRPc−0.001−0.0010.000
AME95% CIa
Study period after eCIP introduction0.3600.2550.465
Male patient−0.058−0.1450.029
Patient age at care episode0.002−0.0010.005
Patient comorbidities
 Hypertension−0.120−0.228−0.011
 Diabetes0.007−0.0980.112
 Venous insufficiency0.066−0.0720.205
 Arteriosclerosis obliteransb−0.069−0.2350.096
CRPc−0.001−0.0010.000

Table excluded 21 care episodes with missing information on CRP. Results from logistic models adjusted for within-patient clustering.

a

CI: confidence interval.

b

Peripheral artery disease.

c

CRP: C-reactive protein.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close